Medication Abortion, Under Revised FDA Label, Should Be the Preferred Option for Early Abortion

Authors

Xingyuan Wang, Touro University Nevada
Pacific Vo, Touro University Nevada
Weldon Havins, Touro University NevadaFollow

Document Type

Abstract

Publication Date

2017

Recommended Citation

Wang, X., Vo, P., & Havins, W. (2017). Medication Abortion, Under Revised FDA Label, Should Be the Preferred Option for Early Abortion. The Journal of Legal Medicine, 37 (Suppl. 1), 1-2. https://doi.org/10.1080/01947648.2017.1479125

Publisher's Statement

The original material can be found here: https://doi.org/10.1080/01947648.2017.1479125